Skip to main content
An official website of the United States government
Program Official
Principal Investigator
Eric Whitman
Awardee Organization

Atlantic Health System, Inc.
United States

Fiscal Year
2025
Activity Code
UG1
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date

The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC Corp)

As the first NCORP Community Site in the state, AHCC CORP serves three-quarters of the New Jersey population. AHCC CORP expands the NCORP network by 6.5M people, advancing the state of the science in cancer prevention, control, screening, care delivery research, and precision medicine studies through biospecimen collection, as well as providing critical access to treatment and imaging studies conducted by the National Clinical Trials Network. With a higher cancer incidence rate than the US as a whole, New Jersey is an important area for cancer prevention and control research. Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC-CORP) is the first NCORP Community Site within the state of New Jersey and combines the collective strengths of world-class healthcare systems with community oncology care delivery. AHCC-CORP covers a geographically diverse area representing 73% of New Jersey’s population. AHCC-CORP expands the NCORP network by 6.5M people; with a higher cancer incidence rate than the US as a whole (477.5 vs 441.2 cases per 100,000). Regions of AHCC-CORP are even further elevated.